Listed on
(Coverage)
JCR2019-2023
SJR2010-2020;2022-2023
CiteScore2011-2023
SCIE2019-2024
CC2019-2024
SCOPUS2017-2024
DOAJ2017-2024
EMBASE2016-2024
OA Info.
| OA |
oa mark
based on the information
- 2017;2018;2019;2020;2021;2022;2023;2024;2025;
|
| Keywords |
drugs |
| Review Process |
Anonymous peer review |
Journal info.
pages |
|
| Licences |
CC BY |
| Copyrights |
Yes |
| DOAJ Coverage |
Added on Date : 2005-01-21T13:02:49Z |
| Subject(s) |
Medicine: Pharmacy and materia medica |
Country
SWITZERLAND
Aime & Scopes
Our aim is to publish updated reviews as well as research articles with comprehensive theoretical and experimental details. Short communications are also accepted; therefore, there is no restriction on the length of a paper.
The multidiciplinary journal welcomes manuscripts covering a wide range of aspects involved in drug discovery and development. The following topics are considered:
Small molecules as drug candidates: drug discovery, drug design, medicinal chemistry, combinatorial chemistry, SAR, structure-property correlations, molecular modeling, pharmacophore, and bioinformatics;
Biomolecules, natural products, phages, and cells as therapeutic tools: peptides, aptamers, glycans, antibodies, extracts, bacteriophages, and stem cells;
Biological targets and biomarkers: enzymes, receptors, membranes, genes, ion channels, inhibitors, agonists, antagonists, neurons, binding affinity, biofilms, bacteria, viruses, parasites, and protein–protein interactions;
Radiopharmaceutical sciences, radiochemistry, (hybrid-)imaging, and nuclear medicine: radiopharmaceuticals, radiotracers, fluorescent dye labeled tracers, contrast agents, PET/CT, PET/MRI RMI, SPECT/CT, and scintigraphy;
Pharmacokinetics and pharmacodynamics: pharmaceutical analyses, drug effects, ADME, animal experimentation, and clinical trials;
Pharmaceutical preparations and drug delivery: dosage form design, bioconjugates, prodrugs, formulation, metabolites, nanomaterials, nanomedicines, and drug targeting.
